Last Published 04.01.2026 Effective Date: 04.01.2026 This policy addresses arterial compliance testing using waveform analysis, carotid intima-media thickness (CIMT) measurement, advanced lipoprotein analysis, endothelial function assessment, and tests for lipoprotein-associated phospholipase A2 (Lp-PLA2) enzyme, other human A2 phospholipases, long-chain omega-3 fatty acids, and multi-protein biomarkers
The Phase 3 trials show Tesamorelin reduces VAT by approximately 15-17.5% over 26-52 weeks compared to placebo
Ready to explore whether GLP-1 injections are the right solution for you
The drug is off to one of the strongest launches in pharma history
Cumulus cells accelerate oocyte aging by releasing soluble Fas Ligand in mice
Diverticular disease is a medical condition that occurs when small protrusions, known as diverticula, develop in the wall of the colon